Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells. - Wikidata - awgldk - TriplyDB

Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells.

Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells.

http://www.wikidata.org/entity/Q36371632

about

Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells.Adoptive immunotherapy for cancer: building on success Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma Cancer immunotherapy: moving beyond current vaccines IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T cells Adoptive cell transfer: a clinical path to effective cancer immunotherapy Tumor-specific Th17-polarized cells eradicate large established melanoma Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells Cancer regression in patients after transfer of genetically engineered lymphocytes Immune evasion by murine melanoma mediated through CC chemokine receptor-10 Doxorubicin and paclitaxel enhance the antitumor efficacy of vaccines directed against HER 2/neu in a murine mammary carcinoma model Optimized tumor cryptic peptides: the basis for universal neo-antigen-like tumor vaccines Identifying Individual T Cell Receptors of Optimal Avidity for Tumor Antigens Engineering opportunities in cancer immunotherapy Adoptive T-cell transfer therapy and oncogene-targeted therapy for melanoma: the search for synergy New perspectives on the role of vitiligo in immune responses to melanoma Sorting through subsets: which T-cell populations mediate highly effective adoptive immunotherapy?Targeting and utilizing primary tumors as live vaccines: changing strategies Advances in the treatment of metastatic melanoma: adoptive T-cell therapy Identification of the genomic insertion site of Pmel-1 TCR α and β transgenes by next-generation sequencing Detection of intra-tumor self antigen recognition during melanoma tumor progression in mice using advanced multimode confocal/two photon microscope Proline substitution independently enhances H-2D(b) complex stabilization and TCR recognition of melanoma-associated peptides Improving Adoptive T Cell Therapy: The Particular Role of T Cell Costimulation, Cytokines, and Post-Transfer Vaccination Adjuvants for peptide-based cancer vaccines Overcoming tumor immune evasion with an unique arbovirus Cish actively silences TCR signaling in CD8+ T cells to maintain tumor tolerance Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiation Impaired gp100-Specific CD8(+) T-Cell Responses in the Presence of Myeloid-Derived Suppressor Cells in a Spontaneous Mouse Melanoma Model Trafficking of high avidity HER-2/neu-specific T cells into HER-2/neu-expressing tumors after depletion of effector/memory-like regulatory T cells Quantitating T cell cross-reactivity for unrelated peptide antigens B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells Immunosuppressive strategies that are mediated by tumor cells Low-Intensity Focused Ultrasound Induces Reversal of Tumor-Induced T Cell Tolerance and Prevents Immune Escape.Immune responses in a mouse model of vitiligo with spontaneous epidermal de- and repigmentation.Histotripsy methods in mechanical disintegration of tissue: towards clinical applications Expression of a Chimeric Antigen Receptor in Multiple Leukocyte Lineages in Transgenic Mice Relapse or eradication of cancer is predicted by peptide-major histocompatibility complex affinity Combining cytotoxic and immune-mediated gene therapy to treat brain tumors

P2860

Q24530100-76FCAEB8-D281-493C-89B6-061F311F1DA4 Q24540135-5E46A2AF-D808-4BCD-B2AF-F72A22B1B130 Q24540429-2CB848EA-4BCB-40B4-9C35-917197878CCD Q24546258-691C082F-A946-42AD-BAA0-2E70B78FD0F0 Q24548019-021B9143-557A-4936-8563-BEABDA8CD91C Q24548229-F18DA0A4-81A3-4A4D-AAFE-DCAE2051B39D Q24621753-91AD133E-6368-4E4A-B105-F5DEEC196626 Q24644774-7C9EEA91-0BF5-4877-8886-CC422179C940 Q24648032-D0017C91-CF4D-4146-967F-F0E4AC36B5E3 Q24651232-C9E870FC-447D-4EC8-B3D3-519D07B17168 Q24654976-5A52B545-838B-4B85-B0AD-88D06B9F5B06 Q24672380-FAF2822E-DE6B-4B74-8A7E-3DD12D586FA1 Q24805875-EA588584-9748-4457-A0FD-26A8F6DA8165 Q26738680-0EA02920-3A2A-40A9-9FE1-376561293B65 Q26774669-103DAE71-F5C0-4B29-8BE8-AED2074B49B0 Q26776373-5DBBD14C-585B-437A-97A6-46D08322B42D Q26822793-C02B7874-B0D3-4B9D-AD24-AC721060FF3E Q26996799-045E7D2C-0F2B-4094-B118-2DD02F467757 Q27002575-CC4CCE63-B815-47B6-82C8-E1275EB8DEA3 Q27009348-57399E22-EB57-4E10-ABA1-9D5EA40C67FA Q27027803-5EA4B223-F33B-4EF4-89BF-CCA8D96EC33A Q27334215-E70F9465-155C-4661-80A1-2A2393BAEDAC Q27334728-8CD33028-5321-493A-9800-9A2CEB04F186 Q27685375-F6CB418D-33AE-40CB-BE9D-489DB3C9BED2 Q28068378-9F6D9AF5-98ED-415E-AE4E-6590CD86B64D Q28072236-CCD6FE07-4BB6-4000-8C32-C254A436E15B Q28081774-6714850B-8070-489E-A59F-95DC5F7CB371 Q28269352-84075DF7-B030-4451-ADC9-AE39CFB9E2FE Q28270256-E7A3C851-E5A9-4E90-A7FA-5C75777943A4 Q28607232-5C31DE81-310E-411A-B06A-EFB1C0FF4654 Q28732041-B35E906E-D413-425E-BDEA-21917622C1AD Q28750512-C5E0AD8F-0024-4124-86FB-DEDD0E1ECA09 Q29620717-C037A0D3-3C61-4A93-89B5-5F9FA3036B51 Q29636247-384A8712-D2AF-4E28-8DD5-EAB2E0C2D0A3 Q30363260-985C3B77-10E7-4A57-AB57-3FF709FEBC21 Q30371711-06AC708B-5D65-4683-B2E1-DCD047D8F9BB Q30389693-47F822DD-C121-4EBE-920E-060A1964F969 Q30399332-7C757482-35F2-4AEC-A580-2108A39AA773 Q30413827-FEA82F9F-7E2C-4540-B662-0E243EBAC298 Q31013320-15CCA9D2-302C-43ED-9B7A-9D1DE0DFA813

P2860

Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells.

http://www.wikidata.org/entity/Q36371632

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh

2003年學術文章

@zh-hant

name

Tumor regression and autoimmun ...... of self-reactive CD8+ T cells.

@ast

Tumor regression and autoimmun ...... of self-reactive CD8+ T cells.

@en

type

label

Tumor regression and autoimmun ...... of self-reactive CD8+ T cells.

@ast

Tumor regression and autoimmun ...... of self-reactive CD8+ T cells.

@en

prefLabel

Tumor regression and autoimmun ...... of self-reactive CD8+ T cells.

@ast

Tumor regression and autoimmun ...... of self-reactive CD8+ T cells.

@en

P1433

Q36371632-B1098EF3-E402-4B6B-B27E-0D62A3A65D40

P1476

Q36371632-C3F84A56-2629-4054-8EDF-7DA41CBBA0F9

P2093

Q36371632-0754963E-DD49-47C3-902F-D600D26AC954

Q36371632-183CE687-52E1-4439-8114-95797ECB4F13

Q36371632-1B269E44-03AC-439B-BD7E-FB585947F2D6

Q36371632-2B001DC9-7BFC-4F1D-946E-920B49DE9CFD

Q36371632-372F165A-3E3E-4D98-B47F-F8EFE1004AEE

Q36371632-56C0A83D-F1BE-426F-83E4-925BB178AD96

Q36371632-736E939C-0BF2-497F-A0EB-38817EA375F9

Q36371632-7C92460F-5DE0-4A22-B8B8-BBD0FC358152

Q36371632-7CB03A18-7560-47BF-829D-65EEB43E3F0B

Q36371632-7FE38894-66C2-49F9-9DE3-FCD74FA6EAEA

P2860

Q36371632-062C062A-0BF0-402F-B6E0-7CB01BA228AD

Q36371632-0820E478-E4F2-4895-92E9-DE2D5B08CEAE

Q36371632-125F0F7D-2329-4294-98EA-27F9F449FA64

Q36371632-149BDD8D-9EBD-45D0-B284-94614EAD949D

Q36371632-2250CB8E-F947-4D37-B9F1-0F751A550538

Q36371632-23C97D99-BE10-41A7-931A-6CE19A46CB3E

Q36371632-26F21BCF-0D09-4F69-ACD3-642E69BF6751

Q36371632-35B4CAA0-FEF1-4BA7-995C-87E4197AB0C1

Q36371632-501AA3B5-15DA-400D-AAAE-031E7FC5BD48

Q36371632-50BBAC3B-149F-4EAC-AEDE-4702DAD477C2

P304

Q36371632-34BC4E03-2053-473D-BE44-EB0194F82545

P31

Q36371632-F98EF4AC-AD32-470A-95F4-1A809C64B66C

P356

Q36371632-75136783-31AB-4A37-AE5B-A041142B1AFA

P407

Q36371632-7B1987C6-7C9D-425B-A0F8-38338F390785

P433

Q36371632-E8FE6552-8768-4DA6-BB45-1727346E3046

P478

Q36371632-A9CAA78A-EB94-4DE2-BF4B-442E60E1D035

P50

Q36371632-2F64E948-FDA4-447E-BD37-7F8703E8E5CE

Q36371632-41E51E79-819C-4E78-B3A3-EF856FB08825

Q36371632-4A883E29-B79D-45B3-BCD5-5AE653B66982

P577

Q36371632-D1BDE51C-FB2A-4B61-B693-50B7F28CF8F1

P5875

Q36371632-B5C3DF93-FF50-474E-9361-0A46426AE2ED

P698

Q36371632-29B61CD5-E25A-4E17-956F-8F5BB681AE80

P932

Q36371632-28B82B12-2ADF-4B1F-91CF-B23B48846FB6

P356

P1433

Journal of Experimental Medicine

P1476

Tumor regression and autoimmun ...... of self-reactive CD8+ T cells

@en

P2093

Ada M Kruisbeek

http://www.w3.org/2001/XMLSchema#string

David M Heimann

http://www.w3.org/2001/XMLSchema#string

Deborah R Surman

http://www.w3.org/2001/XMLSchema#string

Florry A Vyth-Dreese

http://www.w3.org/2001/XMLSchema#string

Laurina A de Jong

http://www.w3.org/2001/XMLSchema#string

Leroy N Hwang

http://www.w3.org/2001/XMLSchema#string

Lionel Feigenbaum

http://www.w3.org/2001/XMLSchema#string

Marc R Theoret

http://www.w3.org/2001/XMLSchema#string

Paul A Antony

http://www.w3.org/2001/XMLSchema#string

Paul J Spiess

http://www.w3.org/2001/XMLSchema#string

P2860

Normal tissue depresses while tumor tissue enhances human T cell responses in vivo to a novel self/tumor melanoma antigen, OA1

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

Self-tolerance to the murine homologue of a tyrosinase-derived melanoma antigen: implications for tumor immunotherapy

The future of interleukin-2: enhancing therapeutic anticancer vaccines

Immunity against cancer: lessons learned from melanoma.

Progress in human tumour immunology and immunotherapy.

Autoimmunity and the immunotherapy of cancer: targeting the "self" to destroy the "other".

Components of the Rb pathway are critical targets of UV mutagenesis in a murine melanoma model.

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.

Spinning molecular immunology into successful immunotherapy.

P304

569-580

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.20030590

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

198

http://www.w3.org/2001/XMLSchema#string

P50

Nicholas P. Restifo

Christopher A. Klebanoff

P577

2003-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10607540

http://www.w3.org/2001/XMLSchema#string

P698

12925674

http://www.w3.org/2001/XMLSchema#string

P932

2194177

http://www.w3.org/2001/XMLSchema#string